“These three accreditations are a milestone in Charles River’s strategy to create a Center of Excellence in China,” said James C. Foster, president, chairman and chief executive officer of Charles River. “As the leading international CRO with GLP capabilities in China, we are replicating the Company’s high standards of research, safety, humane care and laboratory best practices that globally distinguish Charles River.”